Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-05-11
1996-09-24
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 62, 514912, 536 53, 536 55, 536 551, 536 552, 536 553, A61K 31725, C08B 3708
Patent
active
055591043
ABSTRACT:
A highly pure fraction of hyaluronic acid is disclosed which is non-inflammatory and avoids post-operative complications in ocular surgery. Also disclosed is a process for the preparation of hyaluronic acid characterized by converting hyaluronic acid into a corresponding quaternary ammonium salt and, following purification procedures, reconverting the quaternary ammonium salt into a sodium salt of hyaluronic acid.
REFERENCES:
patent: 4141973 (1979-02-01), Balazs
patent: 4920104 (1990-04-01), DeVore et al.
T. C. Laurent, Chem. and Mol. Biol. of Intracellular Matrix, vol. 2, 1970, pp. 703-732.
Z. Ogawa et al. (Nippon Kayaku Co., Ltd.) JP 01 43,502 Chem. Abstr. 1989, vol. 111, No. 22, 201647a.
O. H. Lowry et al. The Journal of Biological Chemistry, vol. 193 (1951) pp. 265-275.
W. D. Comper et al. Physiological Reviews, vol. 58, No. 1 (1978) pp. 255-315.
K. Meyer Chemical Structure of Hyaluronic Acid, Fed. Proceed, vol. 17 (1958) pp. 1075-1077.
E. A. Balazs et al. Mod. Probl. Ophthal. vol. 10 (1972) pp. 3-21.
U. B. G. Laurent Arch Ophtalmol., vol. 101 (1983) pp. 129-130.
D. Miller et al. Ophtalmic Surgery, vol. 8, No. 6 (1977) pp. 58-61.
D. Miller et al. Ophtalmic Surgery, vol. 11, No. 1 (1980) pp. 19-21.
E. L. Graue et al. Exp. Eye Res, vol. 31 (1980) pp. 119-127.
L. Ozaki et al. Folia Ophthalmological Japonica, vol. 32 (1981) pp. 1301-1305.
M. S. Norn Acta Ophthalmologica, vol. 59 (1981) pp. 587-594.
F. M. Polack et al. Ophthalmology, vol. 88, No. 5, (1981) pp. 425-431.
C. D. Binkhorst Am. Intra-Ocular Implant. Soc. J., vol. 6. No. 4 (1980) pp. 340-341.
L. G. Pape Am. Intra-Ocular Implant. Soc. J., vol. 6, No. 4 (1980) pp. 342-343.
M. S. Passo et al. ARVO Abstracts, 10, 10:45 (1981).
P. Percival Trans. Ophthal. Soc. UK, vol. 102, No. 2 (1982) pp. 294-297.
S. M. McRae et al. American Journal of Ophthalmology, vol. 95 (1983) pp. 332-341.
F. G. Berson et al. American Journal of Ophthalmology, vol. 95 (1983) pp. 668-672.
CA 111:201647a Z. Ogawa et al. -JP 01 43,502 (Nippon Kayaku Co., Ltd).
CA 104:24071r M. Ishioroshi (Q.P. Corp.) JP 60,149,601.
CA 112:79852s R. Numazawa et al. (Mitsubishi Rayon Co., Ltd.) JP01,210,401.
CA 102:84389u Ichimaru Farukosu K.K.-JP 59,166,504.
Lorenzi Silvana
Romeo Aurelio
FIDIA S.p.A.
Fonda Kathleen Kahler
Kunz Gary L.
LandOfFree
Procedure for the purification of hyaluronic acid and fraction o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Procedure for the purification of hyaluronic acid and fraction o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Procedure for the purification of hyaluronic acid and fraction o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1928510